Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.

Compounding for the Dental Patient: A Focus on Ulcers of the Mouth

Author(s):  Bassani August S, Keim David

Issue:  Nov/Dec 2004 - Endotoxin
View All Articles in Issue

Page(s):  436-440

Compounding for the Dental Patient: A Focus on Ulcers of the Mouth Page 1
Compounding for the Dental Patient: A Focus on Ulcers of the Mouth Page 2
Compounding for the Dental Patient: A Focus on Ulcers of the Mouth Page 3
Compounding for the Dental Patient: A Focus on Ulcers of the Mouth Page 4
Compounding for the Dental Patient: A Focus on Ulcers of the Mouth Page 5

Download in electronic PDF format for $65

Abstract:  Many unique therapeutic challenges in dentistry call beyond the realm of commercially available solutions. As a partner-in-care, the compounding pharmacist has the potential to make significant contributions to the care of dental patients. One area in which this is particularly true is the common oral ulcers, especially recurrent aphthous stomatitis (canker sores), herpes simplex ulcers (cold sores), and lichen planus. The most common symptom of these conditions is pain. Treatment strategies include decreasing exposure to predisposing factors or infectious agents (by educating patients) and managing symptoms. Topical therapies are usually adequate in all but the most severe or widespread ulcers. Mucosal adhesion of topical therapies is a problem that can be overcome in some patients by use of a “mucosal bandage,” which is applied as a dry powder and turns to an occlusive gel on hydration. The gel protects the ulcer while it heals and may include anti-infective, anti-inflammatory, wound healing, and analgesic components. Other dosage forms, such as traditional gels or rinses, containing similar components may be more appropriate for some patients. In the initial, acute stage of herpes simplex infection, analgesics may be needed to treat fever and pain. Recurrent herpes ulcers of the lip (herpes labialis), however, usually can be treated with customized lip balm or ointment containing sunscreen as well as anti-infective, anti-inflammatory, and analgesic agents. Although lichen planus may cause no symptoms, the ulcerative form often causes severe pain. Systemic steroids are required in some patients to reduce pain and inflammation, but topical preparations have a tole in symptom relief (eg, anti-inflammatory agents) and modulation of the immune system (eg, mast-cell stabilizers, inhibitors of tumor necrosis factor alpha).

Related Keywords: Gus Bassani, PharmD, mouth ulcers, aphthous ulcers, aphthous stomatitis, herpes simplex, herpes labialis, lichen planus, formulation, misoprostol mucoadhesive anesthetic powder

Related Categories: DENTAL, EAR NOSE THROAT, FORMULATIONS

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Compounding for the Dental Patient: A Focus on Ulcers of the Mouth
Bassani August S
, Keim David
Nov/Dec 2004
Pg. 436-440

Current Concepts in the Treatment of Recurrent Aphthous Ulcers
Bramwell Bethany L
, Williams LaVonn A
Jan/Feb 2011
Pg. 13-18

Case Report: Wound Care of a Diabetic Foot Ulcer
Wynn Tom
Jul/Aug 2004
Pg. 265-267

Recurrent Aphthous Stomatitis: Topical Treatment with Minocycline and Other Evidence-based Agents
Zur Eyal
Nov/Dec 2012
Pg. 462-469

Case Report: Lidocaine Mucoadhesive Buccal Tablets for Local Relief of Mouth Ulcers
Young Jennifer L
, Bogner Robin H
May/Jun 2009
Pg. 214-217

A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin
Riepl Mike
Mar/Apr 2022
Pg. 94-98

Compounding Pearls -- Wound Care: Diabetic Foot Ulcers, Part 1
Riepl Mike
May/Jun 2020
Pg. 182-186

The Basics of Compounding Powders and Granules
Allen Loyd V Jr
Jan/Feb 2001
Pg. 36-39

Misoprostol Mucoadhesive Anesthetic Powder
Allen Loyd V Jr
Jan/Feb 1999
Pg. 49

Valacyclovir 50-mg/mL Oral Liquid
Allen Loyd V Jr
Nov/Dec 2006
Pg. 461

Particle Measuring Systems - USP <797> Environmental Monitoring Solutions